Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche discloses new TLR7 agonists for HBV infections

May 16, 2018

Tesaro identifies new CSF1R inhibitors

May 16, 2018

BioCryst Pharmaceuticals discloses kallikrein inhibitors

May 16, 2018

Shionogi patents new P2X7 antagonists

May 16, 2018

Lilly gains AK-01 with AurKa Pharma acquisition

May 16, 2018

PhoreMost receives new funding

May 16, 2018

TapImmune and Marker Therapeutics agree to merger

May 16, 2018

No improvement seen with LHA-510 in wet age-related macular degeneration trial

May 16, 2018

Phase II results presented for eculizumab in the treatment of Guillain-Barre syndrome

May 16, 2018

GAPVAC-101 trial of biomarker-guided actively personalized vaccines for glioblastoma completed

May 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...